SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-21-042630
Filing Date
2021-08-09
Accepted
2021-08-09 16:08:57
Documents
4
Effectiveness Date
2021-08-09

Document Format Files

Seq Description Document Type Size
1 S-8 sndx-s8.htm S-8 96569
2 EX-5.1 sndx-ex51_14.htm EX-5.1 7970
3 EX-23.1 sndx-ex231_15.htm EX-23.1 2548
4 GRAPHIC gplhsb13tjry000001.jpg GRAPHIC 35367
  Complete submission text file 0001564590-21-042630.txt   156983
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-258628 | Film No.: 211156531
SIC: 2834 Pharmaceutical Preparations